ArticleAmerican journal of ophthalmology case reports2021
Acute macular neuroretinopathy following Pfizer-BioNTech COVID-19 vaccination.
Article in American journal of ophthalmology case reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- A Systematic Review of Ocular Complications Following Different Types of Covid-19 Vaccines.Journal of immunology research · 2025Pooled it
- The characteristics of white dot syndromes following COVID-19 Vaccines: a systematic review.International ophthalmology · 2024Pooled it
- Macular perfusion changes in people administered two types of COVID-19 vaccines: comment.Arquivos brasileiros de oftalmologia · 2024Article
- [A blind spot while reading].Die Ophthalmologie · 2023Article
- Ocular posterior segment complications following COVID-19 vaccination.International ophthalmology · 2023Review
- Acute macular neuroretinopathy following Moderna COVID-19 vaccination.Journal of ophthalmic inflammation and infection · 2023Article
- A Case of Concurrent Acute Macular Neuroretinopathy and Paracentral Acute Middle Maculopathy Following Pfizer-BioNTech COVID-19 Vaccination.Turkish journal of ophthalmology · 2023Article
- Acute Macular Neuroretinopathy and Paracentral Acute Middle Maculopathy during SARS-CoV-2 Infection and Vaccination.Vaccines · 2023Article
- Acute macular neuroretinopathy and COVID-19 vaccination: Case report and literature review.Journal francais d'ophtalmologie · 2023Review
- Transient Increase in Patient Numbers with "Acute Macular Neuroretinopathy" Post SARS-CoV-2 Infection-Case Series During the First Surge of Infection in December 2022.Journal of inflammation research · 2023Article
- Three Cases of Arteritic Anterior Optic Neuropathy Several Months after COVID-19 Vaccination.Case reports in ophthalmological medicine · 2023Article
- Review
- Article
- Multiple attacks of transient monocular visual loss in a previously healthy man: a possible complication after COVID-19 vaccination?International journal of retina and vitreous · 2022Article
- Ischemic retinal events after COVID-19 vaccination.American journal of ophthalmology case reports · 2022Article
- COVID-19 and Acute Macular Neuroretinopathy - An underlying association?Annals of medicine and surgery (2012) · 2022Article
- Ischemic Optic Neuropathy After Administration of a SARS-CoV-2 Vaccine: A Report of 2 Cases.The American journal of case reports · 2022Article
- Paracentral acute middle maculopathy and COVID-19 vaccination: Causation versus coincidence finding.Clinical case reports · 2022Article
- Review
- The Eye of the Storm: COVID-19 Vaccination and the Eye.Ophthalmology and therapy · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo describe a case of acute macular neuroretinopathy (AMN) in a patient immediately following administration of the Pfizer-BioNTech COVID-19 vaccine. OBSERVATIONS: The patient complained of paracentral scotoma supported by paracentral visual field loss on multiple Humphrey visual fields that corresponded to outer retinal pathology on optical coherence tomography. The patient's symptoms resolved without treatment. CONCLUSIONS AND IMPORTANCE: We conclude that the clinical testing demonstrated findings consistent with AMN. AMN may be an exceedingly rare adverse ocular effect of a novel vaccine and likely only in the setting of multiple other risk factors. Despite this, we strongly recommend vaccination against COVID-19.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.